Endothelial Dysfunction: Clinical Trials

1 trial for Endothelial Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Endothelial Dysfunction: new trials by email Literature Review of Endothelial Dysfunction trials Research Report on Endothelial Dysfunction

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neurovascular Effects of Empagliflozin
Empagliflozin (EMPA), Placebo - Blood Pressure, Endothelial Dysfunction
Phase 4Not yet recruitingKanokwan Bunsawat1002026-09-012026-09-02

Narrower conditions

Prehypertension (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Vascular Diseases (1)

Interventions

empagliflozin (1)

Sponsors

Kanokwan Bunsawat (1)

Countries

United States (1)

Top investigators

Kanokwan Bunsawat, PHD (1)